Catalyst Wire Dossier Catalyst Wire Dossier

HODO-22252

· Hyundai Pharm
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HODO-22252, covering 2024-08-29 to 2024-08-29. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Safety and Pharmacokinetic Interaction Between HODO-22251 and HODO-22252 in Healthy Adults [Phase 1]

See pricing